Scilex Holding Company Secures Ongoing Support from Endeavor Distribution LLC

Strategic Insights -

Scilex Holding Company, a revenue-generating company focused on non-opioid pain management products, has announced the continuation of its support from Endeavor Distribution LLC. This partnership will expand access to Scilex's products, including ZTlido, ELYXYB, and GLOPERBA, for thousands of patients suffering from acute and chronic pain. The company has shipped $14 million of commercial products to Endeavor since June 2024 and expects to target the utilization of ZTlido to thousands of pharmacies and extended care outlets nationally.

Key Takeaways:

  • Scilex Holding Company has secured ongoing support from Endeavor Distribution LLC for its commercial products.
  • The partnership will facilitate the distribution of Scilex's products to a wide range of healthcare services outlets across the United States.
  • Scilex has shipped $14 million of commercial products to Endeavor since June 2024, with another pending order of $10 million for the fourth quarter of 2024.
  • The company expects to initially target the utilization of ZTlido to thousands of pharmacies and extended care outlets nationally.
  • Scilex remains committed to its goal of ensuring broad access to non-opioid pain management products.
  • Jaisim Shah, Scilex's Chief Executive Officer, expressed excitement about the partnership, stating it will strengthen progress with key customers and point of care facilities.
  • Scilex's products, including ZTlido, ELYXYB, and GLOPERBA, will be distributed to areas not previously accessible to the company.

Statistics:

  • $14 million: Amount of commercial products shipped to Endeavor since June 2024.
  • $10 million: Pending order for the fourth quarter of 2024.
  • Thousands: Number of pharmacies and extended care outlets targeted for ZTlido utilization.
  • June 2024: Month Scilex entered a multi-year distribution agreement with Endeavor.
  • September 17, 2024: Date FSF, Endeavor, and Scilex entered into an agreement to satisfy the FSF Deposit and terminate the Commitment Side Letter.

Sources:

  • Scilex Holding Company news release, [date not specified].